STK17A anticorps (N-Term)

N° du produit ABIN6990303

Cet anticorps anti-STK17A Polyclonal Lapin (ABIN6990303) détecte spécifiquement STK17A dans WB, ELISA, ICC et IF. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour STK17A anticorps (N-Term) (ABIN6990303)

Antigène: STK17A (serine/threonine Kinase 17a (STK17A))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp STK17A est non-conjugé

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Détail du produit anti-STK17A anticorps

Épitope: N-Term

Specificité: No cross responses to DRAK2, DAP or ZIP kinases.

Purification: DRAK1 Antibody is affinity chromatography purified via peptide column.

Immunogène: DRAK1 antibody was raised against a peptide corresponding to amino acids near the amino terminus of human DRAK1. The immunogen is located within the first 50 amino acids of DRAK1.

Isotype: IgG

Information d'application

Indications d'application: DRAK1 antibody can be used for detection of DRAK1 by Western blot at 1 μ,g/mL. An approximately 50 kDa band can be detected. Antibody can also be used for immunocytochemistry starting at 2 μ,g/mL. For immunofluorescence start at 10 μ,g/mL.

Antibody validated: Western Blot in human samples, Immunocytochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: DRAK1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: DRAK1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur STK17A

Antigène: STK17A (serine/threonine Kinase 17a (STK17A))

Autre désignation: DRAK1

Sujet: DRAK1 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues.

Poids moléculaire: 50 kDa

ID gène: 9263

UniProt: Q9UEE5